SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001815776-24-000046
Filing Date
2024-05-15
Accepted
2024-05-15 16:13:06
Documents
1
Period of Report
2024-05-14

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1715803974.html 4  
1 FORM 4 wk-form4_1715803974.xml 4 3070
  Complete submission text file 0001815776-24-000046.txt   4745
Mailing Address C/O REGULUS THERAPEUTICS INC. 10614 SCIENCE CENTER DRIVE SAN DIEGO CA 92121
Business Address
Chevallard Daniel R. (Reporting) CIK: 0001706176 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40532 | Film No.: 24950826

Mailing Address 445 MARINE VIEW AVE SUITE 320 DEL MAR CA 92014
Business Address 445 MARINE VIEW AVE SUITE 320 DEL MAR CA 92014 858-925-7000
LENZ Therapeutics, Inc. (Issuer) CIK: 0001815776 (see all company filings)

IRS No.: 844867570 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)